$3.760
-0.010 (-0.27%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NEUP Prediction & Forecast by Similar Chart Analysis
Alphio's NEUP stock price prediction model matches the current Neuphoria Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.74 (-0.56%). The 1-week path is $3.95 (+5.08%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Neuphoria Therapeutics Inc Stock?
Neuphoria Therapeutics is not a good buy right now due to significant financial instability and negative market sentiment. The stock has a current price of 3.76, a 1-year change of -68.54%, and an RSI of 30.433, indicating oversold conditions but also a lack of upward momentum. The recent halt in the development of a key Alzheimer's drug has led to a 19% drop in stock price, reflecting investor disappointment and uncertainty about future profitability. The main risk is the company's volatile earnings, with a recent net income loss of -9,906,504 in Q1 2026, which raises concerns about its financial health.
NEUP stock price ended at $3.76 on Friday, after losing -0.27%
Neuphoria Therapeutics Inc (NEUP) last closed at $3.76, losing -0.27%. These facts feed the 1-day and 1-week NEUP price prediction above.
Forecast Drivers
Neuphoria Therapeutics Inc (NEUP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NEUP, ranked by similarity.
Seasonality analysis for NEUP
Historically the probability of a positive August return for NEUP is 57.14%. June offers the highest probability of a positive month at 68.33%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NEUP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $6.09 | $7.24 | $7.80 | +92.44% |
| Sep 2026 | $6.53 | $7.12 | $7.16 | +89.40% |
| Oct 2026 | $6.87 | $8.17 | $8.32 | +117.42% |
| Nov 2026 | $6.83 | $8.21 | $9.32 | +118.38% |
| Dec 2026 | $7.47 | $8.30 | $9.69 | +120.80% |
In 2026, Neuphoria Therapeutics Inc (NEUP) is projected to range from $6.09 to $9.69.
Neuphoria Therapeutics Inc 2026 monthly forecast
In Aug 2026, Neuphoria Therapeutics Inc is projected to average $7.24, with a low of $6.09 and high of $7.80.
In Sep 2026, Neuphoria Therapeutics Inc is projected to average $7.12, with a low of $6.53 and high of $7.16.
In Oct 2026, Neuphoria Therapeutics Inc is projected to average $8.17, with a low of $6.87 and high of $8.32.
In Nov 2026, Neuphoria Therapeutics Inc is projected to average $8.21, with a low of $6.83 and high of $9.32.
In Dec 2026, Neuphoria Therapeutics Inc is projected to average $8.30, with a low of $7.47 and high of $9.69.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.